Astromech buys Form Bio in $230M all-stock deal for gene-medicine tools
What's the deal? Astromech, a Dallas AI company building predictive models of biological change, has acquired computational biology firm Form Bio in an all-stock deal valued at $230 million. Astromech takes over Form Bio's intellectual property, selected contracts and assets, and its team.
What's the endgame? The deal pairs Astromech's models — which use data across species and evolutionary history to predict biological function — with Form Bio's tools for designing genetic medicines and checking genomic quality. The companies say the combination should help researchers catch quality problems at the design stage, cutting the need for purification later.
Form Bio's tools support genetic medicine programs at Eli Lilly, Stanford, Coave Therapeutics, Taysha Gene Therapies and Solid Biosciences. In work with Cure Rare Disease on Duchenne muscular dystrophy, Form Bio says it raised full-genome content from 13% to 59% in under 30 days by redesigning a promoter sequence.
The hire: Form Bio co-founder and former chief executive officer Andrew Busey becomes Astromech's chief AI officer and head of technology. Both companies spun out of Colossal Biosciences, the Dallas de-extinction platform co-founded by George Church and Ben Lamm.
Why now? Form Bio launched in 2022 and has raised more than $40 million. Astromech, also co-founded by Church and Lamm, has raised more than $60 million, including a $20 million round in August led by Robert NelsenDealroom has a profile for this one. Try Dealroom →.
The signal: The all-stock deal fits a broader shift in life sciences, where AI and biotech companies are buying computational-biology capabilities to build integrated research platforms. Recent moves include Anthropic's reported $400 million purchase of Coefficient BioDealroom has a profile for this one. Try Dealroom → and Roche's agreement to acquire PathAI — buyers chasing specialized teams, data and tools rather than drug pipelines.
Read more: dailyaibrief.com
Image credit: John Davidson/Form Bio